Clinical Trials
10
Participants
Prescribed Sternal Precautions vs. Self-Guided Restrictive Care (PEEERC)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-06-01
Completion:
2022-11-21
Conditions
Surgery
Heart Diseases
Heart Failure
Cardiac Valve Disease
Interventions
OTHER
No Results Yet
295
Participants
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-03-09
Completion:
2037-07-29
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
116
Participants
MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2025-11-30
Completion:
2030-09-03
Conditions
Hip Arthritis
Hip Disease
Hip Fractures
Hip Injuries
Hip Pain Chronic
Interventions
DEVICE
No Results Yet
42
Participants
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-12-15
Completion:
2027-06-30
Conditions
Lung Adenocarcinoma
Lung Large Cell Carcinoma
Lung Non-Squamous Non-Small Cell Carcinoma
Stage III Lung Cancer AJCC v8
Interventions
DRUG
PROCEDURE
BIOLOGICAL
RADIATION
No Results Yet
10120
Participants
Weight Loss Clinical Decision Support
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2023-04-19
Completion:
2025-10-31
Conditions
Diabetes Mellitus, Type 2
Obesity
Interventions
BEHAVIORAL
No Results Yet
50
Participants
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-11-16
Completion:
2026-03-31
Conditions
Metastases
Interventions
DRUG
No Results Yet
8
Participants
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-04-04
Completion:
2023-08-14
Conditions
Gynecologic Cancer
Colorectal Cancer
Pancreatic Cancer
Non-small Cell Lung Cancer
Cholangiocarcinoma
Ovarian Cancer
Endometrial Cancer
Ovarian Carcinoma
Ovary Neoplasm
Squamous Cell Lung Cancer
Adenocarcinoma of Lung
Adenosquamous Cell Lung Cancer
Interventions
BIOLOGICAL
80
Participants
Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-08-01
Completion:
2024-06-05
Conditions
Cough
Idiopathic Pulmonary Fibrosis
Interventions
DRUG
46
Participants
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-09-19
Completion:
2026-06-01
Conditions
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Head and Neck Carcinoma of Unknown Primary
Locally Advanced Head and Neck Squamous Cell Carcinoma
Locally Advanced Hypopharyngeal Squamous Cell Carcinoma
Locally Advanced Laryngeal Squamous Cell Carcinoma
Locally Advanced Nasal Cavity Squamous Cell Carcinoma
Locally Advanced Oral Cavity Squamous Cell Carcinoma
Locally Advanced Oropharyngeal Squamous Cell Carcinoma
Locally Advanced Paranasal Sinus Squamous Cell Carcinoma
Locally Advanced Sinonasal Squamous Cell Carcinoma
Maxillary Sinus Squamous Cell Carcinoma
Stage III Hypopharyngeal Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage III Sinonasal Cancer AJCC v8
Stage IVA Hypopharyngeal Carcinoma AJCC v8
Stage IVA Laryngeal Cancer AJCC v8
Stage IVA Lip and Oral Cavity Cancer AJCC v8
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVA Sinonasal Cancer AJCC v8
Stage IVB Hypopharyngeal Carcinoma AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVB Lip and Oral Cavity Cancer AJCC v8
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVB Sinonasal Cancer AJCC v8
Interventions
PROCEDURE
DRUG
RADIATION
No Results Yet
84
Participants
A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2024-09-21
Completion:
2027-01-31
Conditions
Port-wine Birthmarks
Port-Wine Stain
Nevus Flammeus
Interventions
DRUG
DEVICE
No Results Yet
Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
Study Type:
EXPANDED_ACCESS
Last Updated:
2025-11-10
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
300
Participants
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2021-11-18
Completion:
2028-04-30
Conditions
Relapsed/Refractory Multiple Myeloma
Interventions
OTHER
No Results Yet
107
Participants
Feasibility Testing a Meditation App for Youth in the Legal System
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-04-05
Completion:
2025-10-15
Conditions
Behavioral Health
Interventions
BEHAVIORAL
No Results Yet
11
Participants
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-06-29
Completion:
2026-01-15
Conditions
T-Cell Large Granular Lymphocyte Leukemia
Interventions
DRUG
No Results Yet
290
Participants
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-01-14
Completion:
2027-09-24
Conditions
DLBCL
Diffuse Large B-Cell Lymphoma
Interventions
BIOLOGICAL
DRUG
No Results Yet
150
Participants
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-12-06
Completion:
2027-01-01
Conditions
Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Locally Recurrent Head and Neck Squamous Cell Carcinoma
Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma
Locally Recurrent Laryngeal Squamous Cell Carcinoma
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Locally Recurrent Oropharyngeal Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Hypopharyngeal Squamous Cell Carcinoma
Metastatic Laryngeal Squamous Cell Carcinoma
Metastatic Melanoma
Metastatic Oral Cavity Squamous Cell Carcinoma
Metastatic Oropharyngeal Squamous Cell Carcinoma
Recurrent Melanoma
Stage III Hypopharyngeal Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IV Hypopharyngeal Carcinoma AJCC v8
Stage IV Laryngeal Cancer AJCC v8
Stage IV Lip and Oral Cavity Cancer AJCC v8
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Unresectable Melanoma
Interventions
PROCEDURE
DRUG
BIOLOGICAL
No Results Yet
95
Participants
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-06-15
Completion:
2026-02-28
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG
No Results Yet
65
Participants
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-11-03
Completion:
2024-06-09
Conditions
Anemia
Iron-deficiency
Interventions
DRUG
35
Participants
Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2018-05-24
Completion:
2027-01-31
Conditions
Cancer
Diabetes
Interventions
OTHER
No Results Yet
109
Participants
A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-03-01
Completion:
2023-03-29
Conditions
Relapsing Multiple Sclerosis
Interventions
DRUG
99
Participants
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-08-11
Completion:
2025-12-19
Conditions
Anal Melanoma
Bladder Melanoma
Cervical Melanoma
Esophageal Melanoma
Gallbladder Melanoma
Head and Neck Mucosal Melanoma
Mucosal Melanoma
Nasopharyngeal Mucosal Melanoma
Oral Cavity Mucosal Melanoma
Penile Mucosal Melanoma
Rectal Melanoma
Recurrent Mucosal Melanoma
Sinonasal Mucosal Melanoma
Urethral Melanoma
Urinary System Mucosal Melanoma
Vaginal Melanoma
Vulvar Melanoma
Interventions
PROCEDURE
DRUG
BIOLOGICAL
No Results Yet
11
Participants
Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2024-04-22
Completion:
2027-12-30
Conditions
Hematological Malignancy
Interventions
DRUG
No Results Yet
780
Participants
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-03-10
Completion:
2028-07-31
Conditions
Relapsed/Refractory Follicular Lymphoma
Marginal Zone Lymphoma
Interventions
DRUG
No Results Yet
40
Participants
Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-06-07
Completion:
2025-03-13
Conditions
Dysexecutive Syndrome
Post-Acute Sequelae of COVID-19
Interventions
DEVICE
No Results Yet
151
Participants
A Long-term Extension Study of Ustekinumab in Pediatric Participants
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-10-18
Completion:
2027-09-29
Conditions
Crohn Disease
Colitis, Ulcerative
Arthritis, Psoriatic
Interventions
DRUG
No Results Yet
30
Participants
Haiti Community Health Workers (CHW) Adaptation
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2023-02-23
Completion:
2025-08-31
Conditions
Heart Failure
Interventions
OTHER
No Results Yet
137
Participants
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-03-07
Completion:
2028-05-31
Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG
No Results Yet
48
Participants
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-08-30
Completion:
2026-12-10
Conditions
Arthritis, Juvenile
Interventions
DRUG
No Results Yet
587
Participants
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-10-14
Completion:
2028-12-08
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
450
Participants
Longitudinal Bladder Cancer Study for Tumour Recurrence
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2022-06-08
Completion:
2026-05-30
Conditions
Urothelial Bladder Cancer
Interventions
DIAGNOSTIC_TEST
No Results Yet
27
Participants
A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-10-01
Completion:
2026-10-31
Conditions
Prostate Cancer
Interventions
DRUG
PROCEDURE
No Results Yet
350
Participants
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-12-07
Completion:
2026-04-06
Conditions
Stereotypical Prolonged Seizures
Interventions
DRUG
OTHER
No Results Yet
300
Participants
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-02-03
Completion:
2028-11-30
Conditions
Stereotypical Prolonged Seizures
Interventions
DRUG
No Results Yet
1586
Participants
Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-11-30
Completion:
2027-12-31
Conditions
AIDS-Related Anal Carcinoma
AIDS-Related Cervical Carcinoma
High Grade Anal Intraepithelial Neoplasia
High Grade Cervical Intraepithelial Neoplasia
HIV Infection
Interventions
PROCEDURE
No Results Yet
155
Participants
Natural History Study of CADASIL
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2022-04-18
Completion:
2034-06-01
Conditions
Cardiovascular Disease
Arterial Stiffness
Germline Mutation in the NOTCH 3 Gene
Pathogenesis of CADASIL
Clinical Phenotype of CADASIL
Interventions
DEVICE
No Results Yet
104
Participants
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-02-02
Completion:
2027-05-06
Conditions
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
Interventions
DRUG
OTHER
No Results Yet
15
Participants
Impact Of Muscle Vibration On Gait Control
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-10-04
Completion:
2025-12-31
Conditions
Muscle
Interventions
DEVICE
No Results Yet
222
Participants
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-12-01
Completion:
2026-04-30
Conditions
Relapsed/Refractory Small Cell Lung Cancer
Interventions
DRUG
No Results Yet
223
Participants
A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-11-04
Completion:
2025-05-30
Conditions
Metastatic Hormone-sensitive Prostate Cancer
Interventions
DRUG
OTHER
No Results Yet
10
Participants
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2021-04-15
Completion:
2026-05-01
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Interventions
OTHER
No Results Yet
Showing 40 trials per page ยท Total 557382 trials